关于公布2014年度国家自然科学基金申请项目评审结果的通告

2014-08-18 国家自然科学基金委员会 国家自然科学基金委员会

国科金发计〔2014〕57号国家自然科学基金委员会在2014年度项目申请集中接收期间共接收各类项目申请151445项,经初步审查受理147270项。根据《国家自然科学基金条例》、国家自然科学基金相关类型项目管理办法的规定和专家评审意见,决定资助面上项目、重点项目、部分重大项目、创新研究群体项目、优秀青年科学基金项目、青年科学基金项目、地区科学基金项目、海外及港澳学者合作研究基金项目、重点国际(地区

国科金发计〔2014〕57号

国家自然科学基金委员会在2014年度项目申请集中接收期间共接收各类项目申请151445项,经初步审查受理147270项。根据《国家自然科学基金条例》、国家自然科学基金相关类型项目管理办法的规定和专家评审意见,决定资助面上项目、重点项目、部分重大项目、创新研究群体项目、优秀青年科学基金项目、青年科学基金项目、地区科学基金项目、海外及港澳学者合作研究基金项目、重点国际(地区)合作研究项目、国家重大科研仪器研制项目(自由申请)和部分联合基金项目,合计35641项。其余项目正在评审过程中。

有关评审结果将通知相关依托单位,科研管理人员可在8月18日后登录科学基金网络信息系统(https://isis.nsfc.gov.cn)查询本单位申请项目评审结果。申请项目批准资助通知、不予资助通知及专家评审意见将以电子邮件形式告知申请人。

申请人如对不予资助决定有异议,可在9月8日前向国家自然科学基金委员会提出复审申请。有关不予资助项目复审申请、受理及审查工作程序和要求见附件。

欢迎各依托单位和科研人员对国家自然科学基金项目评审工作提出意见和建议。

附件2014年度国家自然科学基金不予资助项目复审申请、受理及审查工作程序和要求.doc


国家自然科学基金委员会

2014年8月15日

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
    2014-08-20 222.244.249.207

    好快呀!!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
    2014-08-20 222.244.249.207

    medsci上可以查询了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1802081, encodeId=cbcc1802081ef, content=<a href='/topic/show?id=c865e48473c' target=_blank style='color:#2F92EE;'>#科学基金申请项目#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74847, encryptionId=c865e48473c, topicName=科学基金申请项目)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4193478, createdName=wgx306, createdTime=Mon Jan 05 15:46:00 CST 2015, time=2015-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2032910, encodeId=5252203291066, content=<a href='/topic/show?id=0675e48461d' target=_blank style='color:#2F92EE;'>#科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74846, encryptionId=0675e48461d, topicName=科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c5e117, createdName=lujian, createdTime=Thu Jun 04 06:46:00 CST 2015, time=2015-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086051, encodeId=08b9208605101, content=<a href='/topic/show?id=1b259152548' target=_blank style='color:#2F92EE;'>#评审结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91525, encryptionId=1b259152548, topicName=评审结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Mon May 04 16:46:00 CST 2015, time=2015-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11193, encodeId=9d9011193b6, content=好快呀!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:07:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11192, encodeId=c41c11192e2, content=medsci上可以查询了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=222.244.249.207, createdTime=Wed Aug 20 21:06:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1337939, encodeId=7711133e939ef, content=<a href='/topic/show?id=a6598626921' target=_blank style='color:#2F92EE;'>#自然科学基金#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86269, encryptionId=a6598626921, topicName=自然科学基金)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Wed Aug 20 00:46:00 CST 2014, time=2014-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11161, encodeId=09541116169, content=你有没有中?, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=斯螽, createdTime=Mon Aug 18 13:55:00 CST 2014, time=2014-08-18, status=1, ipAttribution=)]
    2014-08-18 斯螽

    你有没有中?

    0

相关资讯

沈卫峰:2014 ESC/EACTS血运重建指南管窥

上海交通大学医学院附属瑞金医院   沈卫峰 2010年8月,欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)联合发布了ESC/EACTS血运重建指南,对冠心病的3种主要治疗手段——药物治疗、介入治疗和外科手术治疗进行了客观评价,并对血运重建围术期可能发生的问题及合并的临床情况进行了阐述,该指南被临床医生评价为一部“实用性指南”。时隔四年, 20

ASCO 2014:徐兵河教授对话ASCO主席Clifford Hudis教授谈乳腺癌研究50年

第50届美国临床肿瘤学会年会(ASCO2014)于2014年5月30日至6月3日在美国芝加哥召开。芝加哥时间5月31日下午,在ASCO">ASCO2014年会上,中国医学科学院附属肿瘤医院徐兵河教授对话ASCO现任主席Clifford Hudis教授,两位乳腺癌专家就过去50年尤其是过去一年乳腺癌领域的最新进展,ER阳性、HER2阴性的晚期乳腺癌治疗,以及三阴性乳腺癌的治疗等问题进行了深入的

ASCO 2014:从Ph染色体到幸存者问题:血液肿瘤研究的50年进展

血液肿瘤研究进展纪年表 1970s 1964年:基于形态学和细胞化学诊断血液肿瘤 1970年:氮芥+长春新碱+甲基苄肼+泼尼松(MOPP)方案提供了系统治疗晚期肿瘤的首个范例;异体骨髓移植首次应用于治疗血液肿瘤 1971年:开发了Ann Arbor分期系统,提供了重要的预后信息,使疾病程度和结果的相关性系统化。更重要的是,提供了仔细制定放疗计划的框架,且至目前只进行过一处小的修改。 19

ADA2014精彩抢先知

美国糖尿病学会第74届年会(ADA 2014)将于当地时间6月13~17日在旧金山举行,今年的会议有哪些精彩内容不容错过呢,让我们先睹为快! 第四届CMT-ADA 中国学术专场 《中国医学论坛报》(CMT)与ADA 独家合作设立的学术专场今年已是第四届,将在会议第1天(6月13日)作为重头戏上演。 主席口头报告专场 6月17日(星期二)上午9:45开始主席口头报告专场,并从3000

ASCO 2014会场一瞥:“好学”的中国学者们

中山大学附属肿瘤医院 王思愚 北京大学肿瘤医院 王书航 从左至右,中国医学科学院肿瘤医院王佳玉、中国医学科学院肿瘤医院李峻岭、辽宁省肿瘤医院李晓玲 福建省肿瘤医院黄诚、辽宁省肿瘤医院李晓玲 第50届美国临床肿瘤学会年会(ASCO2014)正在美国芝加哥召开。芝加哥时间6月1日,在肺癌poster highlights session现场,记者

CHC 2014:樊代明院士提倡医、药互为师

7日中国心脏大会(CHC2014)的整合医学论坛“樊代明院士专场”异常火爆。正如韩雅玲院士所讲:每次聆听樊代明院士的讲座不吝于一次头脑风暴和思想启迪。 樊代明院士不论专业和行政工作都取得有目共睹的成绩,与充分应用整合的理念密切相关,整合的理念不局限于医学领域,各学科的整合更重要。 胡盛寿院士也希望本届论坛搭建的整合医学发展平台,能协作、交流和推动以心血管病学为主的整合医学的发展。